Class IITerminatedD-0978-2017
Drug recall · July 19, 2017
Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol recall
Why: Lack of sterility assurance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32
- Lots / codes
Lot #: 20170602@29, Exp 7/17/2017
- Quantity
- 20 bags
- Company
- SCA Pharmaceuticals, Little Rock, AR
- Distribution
- LA, PA, NY, WI
- Initiated
- June 21, 2017 · Voluntary: Firm initiated
- Classified
- July 13, 2017
- Reported
- July 19, 2017
- Ended
- April 3, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJul 19, 2017Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMolSCA Pharmaceuticals · D-0976-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMolSCA Pharmaceuticals · D-0977-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMolSCA Pharmaceuticals · D-0979-2017
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.